A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease
NCT01923584
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Parkinson's Disease
Interventions
DRUG:
EPI-743 400mg
DRUG:
EPI-743 200mg
Sponsor
University of South Florida
Collaborators
[object Object]